Publication | Open Access
Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction
72
Citations
23
References
2010
Year
EPO administration is a promising treatment for AMI.
| Year | Citations | |
|---|---|---|
Page 1
Page 1